Analysen von Michael Leuchten

28.03.19 Bayer buy UBS AG
15.03.19 Merck Neutral UBS AG
07.03.19 Merck buy UBS AG
27.02.19 Bayer buy UBS AG
22.02.19 Bayer buy UBS AG
20.02.19 Sartorius vz. Neutral UBS AG
12.02.19 Bayer buy UBS AG
07.02.19 GSK buy UBS AG
30.01.19 Novartis Neutral UBS AG
29.01.19 Sartorius vz. buy UBS AG
18.01.19 Novartis Neutral UBS AG
02.01.19 GSK buy UBS AG
13.12.18 Sartorius vz. buy UBS AG
06.12.18 Bayer buy UBS AG
04.12.18 GSK buy UBS AG
30.11.18 Novo Nordisk buy UBS AG
26.11.18 Novo Nordisk buy UBS AG
21.11.18 Novartis Neutral UBS AG
13.11.18 Bayer buy UBS AG
05.11.18 Novo Nordisk buy UBS AG
01.11.18 Novo Nordisk buy UBS AG
01.11.18 GSK buy UBS AG
23.10.18 Sartorius vz. Neutral UBS AG
23.10.18 Bayer buy UBS AG
17.10.18 Merck buy UBS AG
11.10.18 Bayer buy UBS AG
10.10.18 Novo Nordisk buy UBS AG
05.10.18 Novo Nordisk buy UBS AG
27.09.18 GSK buy UBS AG
25.09.18 Novartis Neutral UBS AG
18.09.18 Bayer buy UBS AG
11.09.18 Novartis Neutral UBS AG
05.09.18 Bayer buy UBS AG
30.08.18 Bayer buy UBS AG
17.08.18 Bayer buy UBS AG
09.08.18 Merck buy UBS AG
08.08.18 Novo Nordisk buy UBS AG
03.08.18 GSK buy UBS AG
30.07.18 GSK buy UBS AG
26.07.18 GSK buy UBS AG
25.07.18 Novo Nordisk buy UBS AG
25.07.18 GSK buy UBS AG
23.07.18 GSK buy UBS AG
20.07.18 Novartis Neutral UBS AG
19.07.18 Novartis Neutral UBS AG
02.07.18 Novartis Neutral UBS AG
02.07.18 GSK buy UBS AG
26.06.18 Bayer buy UBS AG
26.06.18 Merck buy UBS AG
25.06.18 Novo Nordisk buy UBS AG